Gideon Bollag Selected Research

Gideon Bollag Research Topics

Disease

41	Neoplasms (Cancer) 09/2021 - 12/2003
17	Melanoma (Melanoma, Malignant) 01/2018 - 02/2008
4	Inflammation (Inflammations) 01/2021 - 07/2004
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2013
3	Colorectal Neoplasms (Colorectal Cancer) 02/2013 - 05/2011
2	Disease Progression 09/2021 - 01/2021
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021 - 05/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
2	Leukemia 01/2021 - 12/2013
2	Lung Neoplasms (Lung Cancer) 11/2016 - 02/2014
2	Sarcoma (Soft Tissue Sarcoma) 04/2013 - 08/2010
2	Thyroid Neoplasms (Thyroid Cancer) 01/2010 - 12/2009
1	Plexiform Neurofibroma 11/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Colonic Neoplasms (Colon Cancer) 02/2016
1	Giant Cell Tumors (Giant Cell Tumor) 07/2015
1	Giant Cell Tumor of Tendon Sheath 07/2015
1	Thymoma (Thymic Carcinoma) 02/2015
1	Neurofibroma 01/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012
1	Carcinogenesis 01/2012
1	Keratoacanthoma 01/2012
1	Papillary Thyroid Cancer 12/2011
1	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2011
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 11/2011
1	Fibrosis (Cirrhosis) 11/2011
1	Cysts 11/2011
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Body Weight (Weight, Body) 01/2009
1	Obesity 01/2009
1	Autoimmune Diseases (Autoimmune Disease) 12/2008

Drug/Important Bio-Agent (IBA)

15	VemurafenibIBA 01/2018 - 01/2010
12	Phosphotransferases (Kinase)IBA 09/2021 - 10/2004
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022 - 01/2010
8	pexidartinibIBA 01/2021 - 01/2013
8	Pharmaceutical PreparationsIBA 08/2015 - 12/2004
6	Macrophage Colony-Stimulating FactorIBA 01/2019 - 05/2013
6	PLX 4720IBA 03/2016 - 02/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2008
4	ras ProteinsIBA 02/2016 - 08/2006
4	Proto-Oncogene Proteins B-rafIBA 08/2015 - 09/2010
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011 - 10/2004
3	PLX51107IBA 01/2021 - 01/2018
3	PLX8394IBA 01/2019 - 11/2016
3	Mitogen-Activated Protein KinasesIBA 11/2016 - 10/2004
3	Protein Kinases (Protein Kinase)IBA 11/2016 - 02/2008
2	AndrogensIBA 01/2019 - 03/2015
2	Biological ProductsIBA 11/2016 - 02/2008
2	Amino Acids FDA Link 02/2016 - 08/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2015 - 12/2008
2	CytokinesIBA 03/2015 - 05/2013
2	Sorafenib (BAY 43-9006)FDA Link 11/2013 - 10/2004
2	Codon (Codons)IBA 02/2012 - 07/2010
2	raf KinasesIBA 11/2011 - 10/2004
2	Cytostatic AgentsIBA 01/2010 - 12/2009
2	Adenosine Triphosphate (ATP)IBA 01/2010 - 12/2009
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2005 - 07/2004
1	AZD 6244IBA 11/2022
1	Tyrosine (L-Tyrosine)FDA Link 09/2021
1	Sunitinib (Sutent)FDA Link 09/2021
1	Cyclin D3IBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 05/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	CytosineIBA 01/2018
1	JNK Mitogen-Activated Protein KinasesIBA 08/2015
1	tubulin-specific chaperone CIBA 08/2015
1	quizartinibIBA 06/2015
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 05/2015
1	ABT-737IBA 02/2015
1	MK 2206IBA 02/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2015
1	Type C PhospholipasesIBA 12/2013
1	Cytokine Receptors (Cytokine Receptor)IBA 12/2013
1	Conditioned Culture MediaIBA 05/2013
1	Cell Surface ReceptorsIBA 04/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2013
1	MethyltransferasesIBA 02/2013
1	Doxycycline (Periostat)FDA LinkGeneric 12/2011
1	Oncogene Proteins (Oncogene Protein)IBA 12/2011
1	CollagenIBA 11/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011
1	Calcibiotic Root Canal SealerIBA 05/2011
1	ErbB Receptors (EGF Receptor)IBA 08/2010
1	MitogensIBA 07/2010
1	CholesterolIBA 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	AdiponectinIBA 01/2009

Therapy/Procedure

14	Therapeutics 11/2022 - 02/2010
2	Drug Therapy (Chemotherapy) 01/2019 - 02/2010
1	Cell Transplantation 01/2021
1	Castration 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2014
1	Radiotherapy 05/2013